La 'Misión de los 100 días': el plan de la industria farmacéutica para acelerar la respuesta ante futuras crisis La Federación Internacional de Industrias Farmacéuticas presenta una hoja de ruta para blindar la salud global, subrayando que de nada sirve la tecnología sin sistemas de vacunación sólidos y seguridad jurídica

#Industria | 🔔 #IFPMA presenta una hoja de ruta para blindar la salud global y acelerar la respuesta ante futuras crisis

Medicamentos huérfanos y países en desarrollo: innovación atrapada en sistemas sanitarios anticuados Un nuevo informe de la IFPMA advierte que la limitada prioridad política y la falta de marcos regulatorios específicos impiden que los medicamentos huérfanos lleguen a los pacientes más vulnerables

#Industria | 📌Un nuevo informe de #IFPMA advierte que la falta de regulación impide que los #medicamentos huérfanos lleguen a #pacientes vulnerables

Collaboration Across Africa Is Key To Increasing Clinical Trials - Health Policy Watch In Kenya, toxicologists and epidemiologists face a difficult choice: to pursue better-paid work to support their families, or volunteer as reviewers for

🌍 #Africa bears 25% of the disease burden but hosts only 4% of clinical trials.

💡 “Africa is critical for advancing science and for ensuring medicines work for everyone.” Unlocking this potential means investment, collaboration, and stronger systems. #IFPMA

@h3dfoundation.bsky.social
📖⬇️ & 🙏🔁

Countries Criticise 'Inadequate' Pathogen-Sharing Draft Annex At Start Of Text-Based Talks - Health Policy Watch “Inadequate” and “unbalanced” were some of the complaints levelled against the first draft of a Pathogen Access and Benefit-Sharing (PABS) system when World

⚠️ PABS Draft Under Fire for Lack of Equity

Member States are pushing back on the @who.int’s first draft of the PABS annex, saying it lacks detail on how pathogen data will be shared and the access to resulting medical tools.

✍️ @kerrycullinan.bsky.social

@panaction.bsky.social #ifpma
📖⬇️ & 🙏🔁

Working To Make Africa Attractive For Global Clinical Trials - Health Policy Watch Although 18% of the world’s population lives in Africa, only 3% of clinical trials are conducted on the continent – and the ambition is to increase this

🌍 Africa’s next big leap in global research

Only 3 % of clinical trials take place in Africa — despite 18 % of the world’s population living there.

The ambition: 15 % by 2035, driven by innovation, capacity building + digital tools.

#IFPMA @gatesfoundation.bsky.social @cepi.net @who.int
📖⬇️ & 🙏🔁

Drive To Include Pregnant And Breastfeeding Women And Children In Clinical Trials - Health Policy Watch The first pregnant woman with malaria was enrolled in a clinical trial in Mali to compare three different malaria treatment regimens earlier this month – a

🫃Pregnancy alters absorption, metabolism, blood volume — yet most medicines are never tested in pregnant women.

🏅This is a breakthrough step in enrolling pregnant women in trials.

✍️ @kerrycullinan.bsky.social
@mmv.org @medwma.bsky.social @who.int @runciecwc.bsky.social
#IFPMA #ClinicalTrials

Mobilisers On Motorbikes: The Complex Process Of Involving Communities In Clinical Trials - Health Policy Watch This was a lot of work, but for Luke Kanyangareng, a nurse based in rural West Pokot, adjacent to the Ugandan border, the community is the main stakeholder in

🏍️Mobilisers on motorbikes reached nomadic communities in #Kenya for clinical trials.

Experts agree: engagement is “fundamental, not optional.” Without communities, there are no trials.

✍️ @kerrycullinan.bsky.social
@dndi.org
#IFPMA #GlobalHealth #ClinicalTrials #AfricaHealth

Mobilisers On Motorbikes: The Complex Process Of Involving Communities In Clinical Trials - Health Policy Watch This was a lot of work, but for Luke Kanyangareng, a nurse based in rural West Pokot, adjacent to the Ugandan border, the community is the main stakeholder in

🏍️Mobilisers on motorbikes reached nomadic communities in #Kenya for clinical trials.

Experts agree: engagement is “fundamental, not optional.” Without communities, there are no trials.

✍️ @kerrycullinan.bsky.social
@dndi.org
#IFPMA #GlobalHealth #ClinicalTrials #AfricaHealth

La IFPMA urge a combatir las ENT con inversión y cooperación: salvaría 5 millones de vidas al año La Federación Internacional de Asociaciones y Fabricantes Farmacéuticos trasladará en la Asamblea General de las Naciones Unidas la necesidad de centrarse en el aumento de las enfermedades no transmisibles

#Industria | #IFPMA trasladará en la Asamblea General de las Naciones Unidas la necesidad de centrarse en el aumento de las #ENT

Cost of developing new drugs may be far lower than industry claims, trial reveals Exclusive: MSF calls for transparency after its bill for a trial of TB treatment came to a fraction of the billions claimed by pharmaceutical companies

👇🌏NO DOUBT
"Cost of developing new drugs may be far lower than industry claims, trial reveals" #NewDrugCosts #DrugIndustryClaims #MSF #IFPMA